On November 8, 2017, the Board of Directors of Kala Pharmaceuticals, Inc. appointed Todd Bazemore as Chief Operating Officer of the company effective as of his first date of employment with the company which is expected to be on or about November 20, 2017. Mr. Bazemore served as Executive Vice President and Chief Operating Officer of Santhera Pharmaceuticals (USA) Inc., from September 2016 until November 2017. Prior to joining Santhera, Mr. Bazemore served as Executive Vice President and Chief Commercial Officer of Dyax Corp. between April 2014 and January, 2016.